Jonathan E. Rosenberg
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers 116
- Surgery top 0.1%
- Bladder and Urothelial Cancer Treatments 311
- Urinary and Genital Oncology Studies 168
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 36
- Urology top 0.5%
- Pulmonary and Respiratory Medicine top 0.2%
- Renal cell carcinoma treatment 52
- Prostate Cancer Treatment and Research 30
-
- Multiple and Secondary Primary Cancers 41
-
- Epigenetics and DNA Methylation 31
- Co-authors
- Joaquim BellmuntDaniel P. PetrylakEric J. SmallToni K. ChoueiriDean F. BajorinGuru SonpavdeElisabeth I. HeathBrian I. Rini
- Cited by
- OncologySurgeryCancer Research
- Journals
- Journal of Clinical Oncology (194 papers)Annals of Oncology (29 papers)Clinical Genitourinary Cancer (17 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Jonathan E. Rosenberg
393 papers receiving 13.3k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 5.5k
- Surgery 7.0k
- Cancer Research 2.1k
- Urology 869
- Pulmonary and Respiratory Medicine 4.1k
Countries citing papers authored by Jonathan E. Rosenberg
This map shows the geographic impact of Jonathan E. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan E. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan E. Rosenberg more than expected).
Fields of papers citing papers by Jonathan E. Rosenberg
This network shows the impact of papers produced by Jonathan E. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan E. Rosenberg. The network helps show where Jonathan E. Rosenberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jonathan E. Rosenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 3 | |
| 7 | Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotinbreakdown → | 2022 | 87 |
| 8 | Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancerbreakdown → | 2022 | 163 |
| 9 | 2021 | 21 | |
| 10 | 2020 | 20 | |
| 11 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinomabreakdown → | 2020 | 223 |
| 12 | 2019 | 178 | |
| 13 | 2019 | 4 | |
| 14 | 2019 | 26 | |
| 15 | 2017 | 189 | |
| 16 | 2013 | 73 | |
| 17 | 2012 | 177 | |
| 18 | 2008 | 321 | |
| 19 | A Phase 2 study of the dual MET/VEGFR2 inhibitor XL880 in patients (pts) with papillary renal carcinoma (PRC). | 2007 | 7 |
| 20 | 2004 | 153 |
About Jonathan E. Rosenberg
Jonathan E. Rosenberg is a scholar working on Surgery, Oncology and Cancer Research, having authored 404 papers that have together received 13.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (311 papers), Urinary and Genital Oncology Studies (168 papers), Cancer Immunotherapy and Biomarkers (116 papers), Renal cell carcinoma treatment (52 papers), Multiple and Secondary Primary Cancers (41 papers), Cancer Genomics and Diagnostics (36 papers), Epigenetics and DNA Methylation (31 papers) and Prostate Cancer Treatment and Research (30 papers). The work is most often cited by research in Oncology (5.5k citations), Surgery (7.0k citations) and Cancer Research (2.1k citations). Jonathan E. Rosenberg has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Joaquim Bellmunt, Daniel P. Petrylak, Eric J. Small, Toni K. Choueiri, Dean F. Bajorin, Guru Sonpavde, Elisabeth I. Heath, Brian I. Rini, Bernard H. Bochner and Matthew D. Galsky. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Genitourinary Cancer, Cancer and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.